Janssen Sciences Ireland UC

Lobbying Organisation Janssen Sciences Ireland UC

Date published 21 May, 2024

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2024 to 30 Apr, 2024

Specific Details Engagement with Colm Burke TD on pharmaceutical sector and patient access priorities.

Intended results To reform and modernise the medicines reimbursement process in line with IPHA recommendations. To ensure adequate funding for new medicines reimbursement in 2025. To highlight the importance of the pharmaceutical sector and wider life sciences sector to Cork and to Ireland.

Name of person primarily responsible for lobbying on this activity Fergus Sharpe

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Informal communication (1)

Informal meeting at the 2024 IPHA Conference

Informal communication (1)

Informal meeting at the 2024 Guaranteed Irish Pharmaceutical Forum

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Colm Burke TD (Dáil Éireann, the Oireachtas)